Arkstone
Founded 2018 · 43 employees on LinkedIn · 2 known investors
Find your way into Arkstone
89 people in our graph share verified history with the Arkstone team — schools, employers, funds. One of them is your warm intro.
Lloyd Appelunlockedknows Dave Gross · together at Queens College
×4knows the team · via Cardozo School of Law
×2knows the team · via Fairleigh Dickinson University
×5knows the team · via Queens College
Arkstone develops AI-powered clinical decision support tools to guide healthcare providers in appropriate antibiotic prescribing and antimicrobial stewardship, reducing unnecessary antibiotic use and antimicrobial resistance. The company serves laboratory professionals, infectious disease specialists, and healthcare systems worldwide.
Founders & leadership
Arkstone was founded in 2018 by Dave Gross, Dr. Ari Frenkel, and Sol Levi.
DG
Dave GrossinCo-Founder, Chief Technology OfficerDave Gross is an attorney and software executive who previously founded Empower NY, a property management compliance platform acquired by DMGT in 2015, and has held senior technology and operations roles at Fortune 1000 and startup companies. He holds a JD from Cardozo School of Law and a BA from Queens College.
DA
Dr. Ari FrenkelCo-Founder, Chief Science Officer
SL
IC
Investors · 2
In the news
Frequently asked questions
- What does Arkstone do?
- Arkstone develops AI-powered clinical decision support tools to guide healthcare providers in appropriate antibiotic prescribing and antimicrobial stewardship, reducing unnecessary antibiotic use and antimicrobial resistance. The company serves laboratory professionals, infectious disease specialists, and healthcare systems worldwide.
- Who founded Arkstone?
- Arkstone was founded by Dave Gross, Dr. Ari Frenkel, Sol Levi in 2018.
- Who are Arkstone's investors?
- Arkstone's investors include ArchiMed Pte. Ltd., ARCHIMED Japan.